References
- 1. Peltonen S, Kallionpää RA, Peltonen J. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas. Exp Dermatol 2017;26(7):645-648.
- 2. Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 2009; 61(1): 1-16.
- 3. von Recklinghausen FD. Über die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Festschrift für Rudolf Virchow. Berlin, 1882.
- 4. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44(2):81-8.
- 5. Surchev JK, Nachev S, Todorova LP, et al. Optic Nerve Glioma in Two Sisters with Family History of Neurofibromatosis Type 1. J Neurol Surg A Cent Eur Neurosurg. 2018;79(3):268-272.
- 6. Vlenterie M, Flucke U, Hofbauer LC, et al. Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. Am J Med. 2013;126(2):174-80.
- 7. Allaway RJ, Gosline SJ, La Rosa S, et al. Cutaneous neurofibromas in the genomics era: current understanding and open questions. Br J Cancer 2018;118(12):1539-1548.
- 8. Packer RJ, Fisher MJ, Cutter G, et al. Neurofibromatosis Clinical Trial Consortium. J Child Neurol 2018;33(1):82-91.
- 9. Widemann BC, Acosta MT, Ammoun S, et al. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A 2014; 164(3):563-78.
- 10. Walker JA, Upadhyaya M. Emerging therapeutic targets for neurofibromatosis type 1. Expert Opin Ther Targets 2018;22(5):419-437.
- 11. Rad E, Tee AR. Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Semin Cell Dev Biol 2016; 52:39-46.
- 12. Hanemann CO, Blakeley JO, Nunes FP, et al. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology 2016;87(7 Suppl 1): S40-8.